145 related articles for article (PubMed ID: 11424093)
1. Involvement of Smads in TGFbeta1-induced furin (fur) transcription.
Blanchette F; Rudd P; Grondin F; Attisano L; Dubois CM
J Cell Physiol; 2001 Aug; 188(2):264-73. PubMed ID: 11424093
[TBL] [Abstract][Full Text] [Related]
2. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
Lau MT; Ge W
Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
6. TGFbeta1 regulates gene expression of its own converting enzyme furin.
Blanchette F; Day R; Dong W; Laprise MH; Dubois CM
J Clin Invest; 1997 Apr; 99(8):1974-83. PubMed ID: 9109442
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression.
RodrÃguez-Pascual F; Redondo-Horcajo M; Lamas S
Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
10. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan RP; Chen F; Li W; Vig E; Harrington MA; Nakshatri H; Chen Y
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
[TBL] [Abstract][Full Text] [Related]
11. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
15. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
16. FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.
Bartholin L; Maguer-Satta V; Hayette S; Martel S; Gadoux M; Bertrand S; Corbo L; Lamadon C; Morera AM; Magaud JP; Rimokh R
Oncogene; 2001 Sep; 20(39):5409-19. PubMed ID: 11571638
[TBL] [Abstract][Full Text] [Related]
17. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P
J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283
[TBL] [Abstract][Full Text] [Related]
18. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.
Tsunobuchi H; Ishisaki A; Imamura T
Biochem Biophys Res Commun; 2004 Apr; 316(3):712-9. PubMed ID: 15033458
[TBL] [Abstract][Full Text] [Related]
19. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism.
Zhu X; Topouzis S; Liang LF; Stotish RL
Cytokine; 2004 Jun; 26(6):262-72. PubMed ID: 15183844
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
